ライフサイエンスコーパス: Japan

1 National Institute of Radiological Sciences (Japan).

2 e of six, stratified by region (Japan or non-Japan).

3 rce system (DRI OCT-1 Triton, Topcon, Tokyo, Japan).

4 during the 2014/15 season in Matsumoto city, Japan.

5 76 centers in the United States, Europe, and Japan.

6 ii were found in the Kagoshima population of Japan.

7 d after treatment with baloxavir marboxil in Japan.

8 d sea bream (Pagrus major) in Kagoshima Bay, Japan.

9 n the Yatsuo Group of Miocene age in central Japan.

10 are recognised by local whalers in Hokkaido, Japan.

11 in Hobetsu area of Mukawa town in Hokkaido, Japan.

12 s sampler), at more than 20 locations across Japan.

13 Institute of Radiological Sciences (NIRS) in Japan.

14 hospitals and clinics in the USA and six in Japan.

15 m of traditional martial arts originating in Japan.

16 isolated from a hot, acidic spring in Beppu, Japan.

17 dan from Cladosiphon okamuranus harvested in Japan.

18 ne RP1, neither of which are rare alleles in Japan.

19 ery rare condition and is not common outside Japan.

20 hospitals and clinics in the USA and six in Japan.

21 symptoms related to grass and weed pollen in Japan.

22 silica (BSi) flux from radiolarian chert in Japan.

23 orth Pacific, especially that hits Korea and Japan.

24 pared mostly from actinomycetes from soil in Japan.

25 ed to investigate the effectiveness of IB in Japan.

26 urope, Israel, Australia, Latin America, and Japan.

27 ion phase 1 trial done at two study sites in Japan.

28 orth America, Europe, Israel, Australia, and Japan.

29 be important for patients with pollinosis in Japan.

30 unveiling of a new supported mirror site in Japan.

31 of acute asthma with IB is still uncommon in Japan.

32 -spectrum antiviral drug approved for use in Japan.

33 during 2012-2015 and the type specimen from Japan.

34 he price at which DAAs become cost-saving in Japan.

35 newly introduced pigments in late Edo-period Japan.

36 a is followed by those in France, Spain, and Japan.

37 nd the declining gastric cancer mortality in Japan.

38 productivity from the Chiba Section, central Japan.

39 evention and treatment against pollinosis in Japan.

40 tude North Atlantic and Osaka Bay, southwest Japan.

41 dings for respiratory isolates reported from Japan.

42 for assessing pediatric chronic urticaria in Japan.

43 in Italy, Brazil, Canada, England, Iran, and Japan.

44 pling and seismogenic behaviour in northeast Japan.

45 erthrusting (upper) plate offshore northeast Japan.

46 ndependent validation cohorts in the USA and Japan.

47 We enrolled 14 patients from six centres in Japan.

48 ncy may be an important cause of diabetes in Japan.

49 -season tropical cyclones affecting Okinawa, Japan.

50 rare in Japan, although the ant is native to Japan.

51 osed around the Nobeoka Thrust, southwestern Japan.

52 rsity on subtropical coral reefs in Okinawa, Japan.

53 en volcanic ash from the Sakurajima volcano, Japan.

54 th leading cause of cancer-related deaths in Japan.

55 d a viscoelastic rebound across the whole of Japan.

56 countries, it remains one of the highest in Japan.

57 in some EU countries, but not in the USA or Japan.

58 ss to these products in the EU, the USA, and Japan.

59 could increase dental service utilization in Japan.

60 the acidic, hot spring Umi Jigoku in Beppu, Japan.

61 ive births (range 1:4,500 [Italy]-1:125,000 [Japan]).

62 In Japan, 1.5-2 million people are chronically infected wit

63 r, placebo-controlled, double-blind trial in Japan, 106 ASD individuals (18-48 y.o.) were enrolled be

64 athways were authorised in the EU (2006), in Japan (2009), and in the USA (2015), to facilitate appro

65 alted, and the trial continued comparing BCG-Japan (3,191 neonates randomized, 3,184 analyzed) with B

66 ralization titers (>/=160) in 100% against A/Japan/305/1957 (H2N2), 53% against A/Hong Kong/1073/99 (

67 ilure of fusion pore enlargement among H2 (A/Japan/305/57), H3 (A/Aichi/2/68), and H3 (A/Udorn/72) vi

68 alted, and the trial continued comparing BCG-Japan (3191 neonates randomized, 3184 analyzed) with BCG

69 cts), or 3D Topcon OCT (Topcon, Inc., Tokyo, Japan) (4 studies, 522 subjects).

70 In Japan, a 30% copayment (out of pocket) by the user and a

71 The EU, the USA, and Japan account for the majority of biological pharmacothe

72 s with selected forest maps generated by the Japan Aerospace Exploration Agency (JAXA F/NF), European

73 ld active duty US marine serving in Okinawa, Japan, afflicted with severe CNS angiostrongyliasis mark

74 tion in the United States, Canada, EU15, and Japan alone accounting for approximately 20% of global p

75 However, it is quite rare in Japan, although the ant is native to Japan.

76 t coral tissues collected from five sites in Japan and Australia.

77 ere positioned in a range of climates across Japan and compared over 3 years, against the developed s

78 transition might vary across regions within Japan and concern is growing about increasing regional v

79 nd P=3.10x10(-8)) that replicated in Biobank Japan and confirmed recent findings implicating the BAG3

80 rehistoric human populations from throughout Japan and ecologically comparable groups of macaques.

81 d in the USA and at least 20 years of age in Japan and had advanced solid tumours (regardless of HER2

82 old in the USA and at least 20 years old in Japan and had advanced solid tumours (regardless of HER2

83 e infections, was first described in 2009 in Japan and has since been reported from several countries

84 asure the burden of diseases and injuries in Japan and in the 47 Japanese prefectures from 1990 to 20

85 conditions in the Philippines, India, China, Japan and Italy.

86 tancy, and healthy life expectancy (HALE) in Japan and its 47 prefectures.

87 les from Germany, Malta, China, India, Iran, Japan and Korea and samples of African American ancestry

88 orwegian engineer father, he was educated in Japan and later graduated from the University of Dayton

89 re dataset of 441 patients from the UK, USA, Japan and Martinique who collectively experienced 1976 a

90 s established for only one species living in Japan and no information is available for its luciferin

91 tuff with very high economic value in China, Japan and other countries in south-east Asia.

92 ion Veteran Program (MVP), DIAMANTE, Biobank Japan and other studies.

93 ious gastroenteritis associations throughout Japan and project temperature-related morbidity concomit

94 d adults (aged >/=18 years or >/=20 years in Japan and South Korea) with newly diagnosed advanced NSC

95 ng agents were recruited from three sites in Japan and Spain for a run-in cohort, and from 17 sites i

96 s causing human infections in Brazil, China, Japan and Spain.

97 aged 18 years or older (20 years or older in Japan and Taiwan) at the time of study entry, had stage

98 pulations from neighboring countries (China, Japan and Taiwan) were examined using nine nuclear micro

99 r allele frequencies in a combined cohort of Japan and Taiwan.

100 m 78 sites across six rivers in the mainland Japan and the Amami-Oshima Island, we demonstrate that t

101 lues are predicted across Eastern Europe and Japan and the lowest across Africa, Central America and

102 nd enrolling patients as of July 8, 2017, in Japan and the USA.

103 ersity Graduate School of Medicine, 7910295, Japan' and affiliation 3 incorrectly read 'Department of

104 nts were aged 18 years or older (20 years in Japan) and had treatment-naive, histologically or cytolo

105 , Gamagori, Japan), OCT-HS100 (Canon, Tokyo, Japan), and Revo NX (Optopol Technology SA, Zawiercie, P

106 e enrolled at 21 centres in the USA, Europe, Japan, and Australia.

107 subnational studies from the United States, Japan, and Brazil show associations between area-level i

108 investigated extensively in Europe, the USA, Japan, and China, but little or no data are available fr

109 FTSV), is present in China, South Korea, and Japan, and infections requiring medical attention result

110 ablished in several countries in Europe, and Japan, and it has been intercepted in shipments coming i

111 Thailand, Singapore, Indonesia, Philippines, Japan, and Korea; 46 centres with enrolment between 1 Oc

112 ng in Mifune, a town in Kumamoto Prefecture, Japan, and measured predisaster social capital.

113 gn at 54 sites in Australia, Europe, Israel, Japan, and north America.

114 ice freeze dates (1443-2014) for Lake Suwa, Japan, and of ice breakup dates (1693-2013) for Torne Ri

115 ickel from P-T boundary sections in Hungary, Japan, and Spiti, India suggest that the nickel anomalie

116 ntroduced onto one of the Ogasawara Islands, Japan, and subsequently expanded its range rapidly throu

117 nd regions (Australia, Scandinavia, the USA, Japan, and the UK) between 1946 and 2013.

118 have been increasingly described in Europe, Japan, and the United States, with pigs representing the

119 tern Europe, Australia, Canada, New Zealand, Japan, and the USA).

120 cademic clinical sites in Australia, Europe, Japan, and the USA.

121 ity of temperature-related diarrhea cases in Japan are attributable to viral infections during the wi

122 dominantly in the United States, Europe, and Japan are now carried out globally.

123 ed financial and corporate reporting data in Japan as the base source to construct a financial report

124 xy data from the sediments of Lake Suigetsu (Japan), as evidence that a related bi-partition of the Y

125 In northeastern Japan, aseismic slip occurs in the form of decelerating

126 d injuries, and to attribute risk factors in Japan at a subnational, prefecture-level.

127 ) of a new optical biometer (OA-2000, Tomey, Japan) based on swept-source optical coherence tomograph

128 , Mississippi, and accessions distributed in Japan, based on the double-digest restriction site-assoc

129 ized height-associated loci from the Biobank Japan (BBJ) dataset to further alleviate concerns of bia

130 G-Russia (MRR, 1.15 [95% CI, .74-1.80]); BCG-Japan/BCG-Russia (MRR, 0.71 [95% CI, .43-1.19]).

131 Denmark/BCG-Russia MRR=1.15 (0.74-1.81); BCG-Japan/BCG-Russia MRR=0.71 (0.43-1.19).

132 cted in 126 neonatal intensive care units in Japan between April 2010 and September 2011.

133 ed Kingdom, Spain, The Netherlands, Finland, Japan, Brazil, South Africa, and Australia).

134 tion (e.g., in Central Europe, Indonesia, or Japan but also numerous other places).

135 Cs treated in North America, 1% of HCCs from Japan, but 16% of HCCs from Hong Kong.

136 sed to capture overwork-related CVD rates in Japan by a factor of 0.42 (p-value < 0.05).

137 emerging disease in China, South Korea, and Japan caused by the tick-borne SFTS virus (SFTSV).

138 The Japan Chronic Kidney Disease (CKD) Database (J-CKD-DB) i

139 T5/ST225-MRSA-II, Rhine-Hesse EMRSA/New York-Japan Clone in our setting was detected.

140 179,417 Japanese participants in the BioBank Japan cohort and compared with analogous data from the U

141 The payers of health care in Japan could examine ways to procure DAAs at a price wher

142 CTO lesions attempted using RA had lower Japan-CTO score (2.3+/-1.2 versus 2.5+/-1.3; P<0.001).

143 ome-wide association study using the Biobank Japan dataset (excluding secondary kidney diseases, such

144 eparate datasets, including one from BioBank Japan, DBSLMM achieves an average of 14.74%-522.74% accu

145 otide Archive (ENA) and the DNA Data Bank of Japan (DDBJ) ensures worldwide coverage.

146 ics Institute (EBI) and the DNA Data Bank of Japan (DDBJ).

147 Japan does not permit biosimilar substitution, as prescr

148 nd-Mackay CT scores (a coprimary endpoint in Japan), done in an intention-to-treat population.

149 A H1N1 strain that emerged and circulated in Japan during 2013-14 was 24% (95% CrI 17-30) less transm

150 to low physical activity (LPA) in China and Japan during the period 1990-2016.

151 shed seven months before the 2011 Great East Japan Earthquake and Tsunami in a survey of older commun

152 among older survivors of the 2011 Great East Japan earthquake and tsunami.

153 tial relocation in the aftermath of the 2011 Japan Earthquake and Tsunami.

154 directly in the line of the 2011 Great East Japan Earthquake and Tsunami.

155 es following exposure to the 2011 Great East Japan Earthquake and Tsunami.

156 esidents who experienced the 2011 Great East Japan Earthquake and Tsunami.

157 In March 2011, the Great East Japan Earthquake devastated several power stations and c

158 The 2011 East Japan earthquake generated a massive tsunami that launch

159 non-TH) five years after the 2011 Great East Japan Earthquake.

160 ther than increased following the Great East Japan Earthquake.

161 he northern Philippines, the Ryukyu Islands (Japan), eastern Vietnam, western and eastern Australia,

162 Data for 92,743 pregnant women from the Japan Environment and Children's Study were analyzed in

163 itors have been approved for clinical use in Japan (fasudil and ripasudil) and one in China (fasudil)

164 ity and sensitivity of 25 IRDTs available in Japan for the detection of seasonal H1N1pdm09, H3N2, and

165 blic of China, Da Qing First Hospital, China-Japan Friendship Hospital, and National Center for Cardi

166 rvey, enrolled all AF patients in Fushmi-ku, Japan, from March 2011.

167 ompared with similar surveys from Europe and Japan, geographic variation is observed, with some doses

168 The Japan Gerontological Evaluation Study is a nationwide co

169 ailed a questionnaire to participants in the Japan Gerontological Evaluation Study living in Mifune,

170 a baseline survey as part of the nationwide Japan Gerontological Evaluation Study seven months befor

171 Data were derived from the 2016 Japan Gerontological Evaluation Study.

172 vanced gastrointestinal (GI) cancer in SCRUM-Japan GOZILA (no.

173 INTERPRETATION: Japan has been successful overall in reducing mortality

174 Japan has entered the era of super-ageing and advanced h

175 mals, seawater, and sediment near Fukushima, Japan have become contaminated with (134)Cs and (137)Cs

176 Songs were collected from Philippines, Japan, Hawaii and Mexico in 2011, 2012 and 2013.

177 The Hida Mountain Range of central Japan hosts the youngest exposed plutons on Earth and pr

178 d Duplimab are not indicated for children in Japan, however, it is necessary to consider not only top

179 munity-dwelling older people aged >/=65 y in Japan in 2010, and 85,161 (67.4%) responded.

180 Taiwan followed Japan in putting in place new policies and then updating

181 sastrous flooding of the Kinu River, central Japan, in September 2015.

182 ers HealthCare Biobank, FinnGen, and Biobank Japan including 3554 individuals with cirrhosis and 343,

183 d in the USA, European Union, Australia, and Japan including sympathomimetics, pancreatic lipase inhi

184 Life expectancy at birth in Japan increased by 4.2 years from 79.0 years (95% uncert

185 BCG-Denmark and BCG-Japan induced more BCG scars and PPD reactions than BCG-

186 t predictors of what the Fukushima region of Japan is coping with in terms of health and environmenta

187 ent to the primary nesting areas in southern Japan is remarkably stable and that hatchling dispersal

188 Japan is the only country with a predicted decline in th

189 Industrialized countries (USA, UK, Germany, Japan, Italy, France and Canada) were the most prolific

190 ed to northern Pacific Arc sources including Japan, Kamchatka, Cascades and Alaska.

191 pecified analyses of data from Asian (China, Japan, Korea and Taiwan) patients in the study.

192 ies in Cretaceous amber from Canada, France, Japan, Lebanon, Myanmar, and the United States [12-18] r

193 viral lineages (D/OK-like, D/660-like, and D/Japan-like) have been described.

194 ia, Belgium, Canada, France, Germany, Italy, Japan, Lithuania, Mexico, Netherlands, Poland, Portugal,

195 ark, Finland, Greece, India, Ireland, Italy, Japan, Malta, Netherlands, New Zealand, Norway, Slovenia

196 Japan may experience a net reduction in temperature-rela

197 al (SUSTAIN 1) at 72 sites in Canada, Italy, Japan, Mexico, Russia, South Africa, UK, and USA (includ

198 (moment magnitude 8.8) and 2011 Tohoku-oki, Japan (moment magnitude 9.0) earthquakes were preceded b

199 ldwide biobanks (n(total) = 675,898; BioBank Japan (n = 179,066), UK Biobank (n = 361,194) and FinnGe

200 a unique longitudinal birth cohort sample in Japan (n = 568), we examined whether there was an effect

201 Among patients enrolled in Onyx ONE US/Japan (n=752) and Onyx ONE randomized controlled trial (

202 , and one Japanese-ancestry biobank (BioBank Japan, n = 168 680) were used for additional replication

203 rom seven countries (Denmark, France, Italy, Japan, Netherlands, Portugal, and the UK) evaluated case

204 da, France, Germany, Ireland, Israel, Italy, Japan, New Zealand, Norway, Russia, South Africa, Spain,

205 lia, Canada, France, Germany, Israel, Italy, Japan, New Zealand, Norway, Spain, and USA).

206 , Hong Kong [Special Administrative Region], Japan, New Zealand, Singapore, and South Korea) and four

207 Japan: New Zealand Intervening) in the International Cou

208 S. pombe developed and spread from Europe to Japan, North America, and elsewhere from its beginnings

209 an unrelated HCT done in Australia, Europe, Japan, North America, and the UK between Jan 1, 1988, an

210 involving the United States, Russia, China, Japan, North Korea, Estonia, Israel, Iran, and Syria.

211 1 centres in six countries (Austria, Canada, Japan, Norway, Russia, and the USA).

212 ia, Belgium, Canada, France, Germany, Italy, Japan, Norway, Spain, and the USA.

213 rtnership Grant, World Bank Research Budget, Japan Nutrition Trust Fund, Power of Nutrition, and the

214 Meditec), RS-3000 Advance (Nidek, Gamagori, Japan), OCT-HS100 (Canon, Tokyo, Japan), and Revo NX (Op

215 AS) OCT (Tomey SS-1000 CASIA; Tomey, Nagoya, Japan) of the nasal iridocorneal angle at 2 levels of ac

216 impacts of non-compulsory measures in Tokyo, Japan on human mobility patterns has been under-studied.

217 75 mg/m(2) (60 mg/m(2) in Korea, Taiwan, and Japan) on day 1 of a 21-day cycle.

218 ly academic centres in the USA (65 centres), Japan (one centre), and South Korea (one centre).

219 that the center of origin of the pathogen is Japan or Korea, but biovar 3, which is responsible for t

220 h a block size of six, stratified by region (Japan or non-Japan).

221 oment magnitude 9.0 eathquake in Tohoku-Oki, Japan, or along large collision zones, such as the 1999

222 tories for loggerhead turtles emanating from Japan over six decades (1950-2010).

223 . Anderson Cancer Center group (MDA) and the Japan Pancreas Society (JPS) have introduced other gradi

224 RATIONAL: In Japan patients with Japanese Cedar (JC) pollinosis have

225 sed controlled trial across 292 hospitals in Japan, patients with high-risk non-cardioembolic ischaem

226 in some regions including Vanuatu, southern Japan, Peru and Chile.

227 03197935), Eudra (CT2016-004734-22), and the Japan Pharmaceutical Information Center (JapicCTI-173630

228 nd Drug Administration (FDA), and ten by the Japan Pharmaceuticals and Medical Devices Agency (PMDA).

229 in Canada, Czech Republic, Germany, Hungary, Japan, Poland, and the USA.

230 m Florida and sequences from Czech Republic, Japan, Poland, Slovenia, and the United States.

231 rt, and from 17 sites in Australia, Belgium, Japan, Poland, Spain, and the USA for a subsequent expan

232 nd Life Science Experimental Facility of the Japan Proton Accelerator Complex (J-PARC) for an iron sa

233 d fourth leading cause of death in China and Japan, respectively.

234 ,827 records of lab-analyzed field data from Japan, Russia, Vietnam, Mongolia, Alaska and Influenza R

235 ocket) by the user and a 70% contribution by Japan's universal health insurance (JUHI) are required f

236 latory bodies, including the US, the EU, and Japan, S6821 and S7958 were approved as safe under condi

237 and a south-north transect from Australia to Japan, sampling corals throughout 32 island systems with

238 etails of Pacific plate subduction under the Japan Sea and associated current seismicity remain chall

239 ast of the Lena Basin, coastal basins of the Japan Sea, and the North Pacific Islands.

240 Norikura, Japan, sequencing the ITS2 region.

241 overrepresented in HIV-infected patients in Japan sharing the same HLA genotypes.

242 The projected declines are in China, Japan, Singapore, and parts of Europe (e.g., Estonia, Cz

243 al model to epidemic data from China, Italy, Japan, Singapore, Canada and South Korea.

244 a, Brazil, France, Greece, Hong Kong, Italy, Japan, Singapore, Spain, South Korea, United Kingdom, Un

245 Japan Society for the Promotion of Science, Swiss Nation

246 iations were more obvious in northeast Asia (Japan, South Korea, and Taiwan).

247 s in hospitals and medical centres in China, Japan, South Korea, and Taiwan.

248 cancer research centres in the USA, Israel, Japan, South Korea, and Taiwan.

249 t 116 research centres in Australia, Canada, Japan, South Korea, Mexico, South Africa, Spain, Taiwan,

250 in 11 countries (Canada, UK, Germany, Italy, Japan, South Korea, Taiwan).

251 d cancer centres in Denmark, Germany, Italy, Japan, South Korea, Taiwan, the UK, and the USA.

252 Finland, Germany, Greece, Hungary, Ireland, Japan, South Korea, Taiwan, UK, and USA).

253 ites in seven countries (Australia, Germany, Japan, Spain, Turkey, the USA, and the UK).

254 to the Japanese population and updated with Japan-specific health utilities and costs.

255 kushima Dai-ichi nuclear reactor accident in Japan spread rapidly across the North Pacific Ocean and

256 tion of patients pooled from the Onyx ONE US/Japan study and Onyx ONE randomized controlled trial.

257 h-eastern Italy and native areas, especially Japan, suggesting further introductions from this native

258 Of the countries studied, the USA, Japan, Sweden, Greece, Macedonia, and Serbia have some o

259 ouragingly, some reefs-most notably Vietnam, Japan, Taiwan, New Caledonia and the southern half of th

260 untries in the reference scenario, including Japan, Thailand, and Spain, were forecasted to have popu

261 According to pollen data from Osaka Bay, Japan, the decrease in temperature of the Siberian air m

262 en((R)) is for patients over 12 years old in Japan, the efficacy in Cedarcure((R)) group enhanced bet

263 ls (n = 58,610-165,084) collected by BioBank Japan, the nationwide hospital-based genome cohort.

264 a, Czech Republic, France, Germany, Hungary, Japan, the Netherlands, South Korea, Spain, the UK, and

265 e in China, and in recently invaded areas of Japan, the pheromone attracted both sexes of the beetle.

266 duals from 24 studies with participants from Japan, the Philippines, Korea, China, Singapore, and Tai

267 URFACE 1 (at 118 sites in Australia, Canada, Japan, the UK, and the USA) and reSURFACE 2 (at 132 site

268 , Austria, Canada, Germany, Greece, Ireland, Japan, the UK, and the USA, hypertensive patients with o

269 For BCG-Japan there were 185 admissions versus 161 admissions fo

270 tcomes using a national surgical database in Japan, there is a need to investigate outcomes associate

271 For BCG-Japan, there were 185 admissions vs 161 admissions for B

272 duate School of Medicine, Matsuyama 7910295, Japan.' These errors have now been corrected in both the

273 amics Research (BDR), Suite, Hyogo 565-0874, Japan.' This has now been corrected in both the PDF and

274 the second-highest reported incidence after Japan, though the real anisakidosis burden is unknown be

275 bally spanned from 76.1 years (75.6-76.7) in Japan to 45.6 years (42.6-48.2) in Papua New Guinea.

276 ian Ocean, but also the western Pacific from Japan to Australia is constantly increasing.

277 entury and suggests sequential movement from Japan to North America, as a hitch-hiker on oysters, and

278 tions from Gosan, South Korea, and Hateruma, Japan, together with global monitoring data and atmosphe

279 d normal stresses on the megathrust near the Japan Trench over the seven years before the 2011 Mw 9.0

280 smic faults in drill core recovered from the Japan Trench subduction zone, which hosted 50 m of shall

281 uake-triggered event deposit along the hadal Japan Trench.

282 ic matter from the slope into the >7 km deep Japan Trench.

283 e tomography (SS-OCT) (Casia; Tomey, Nagoya, Japan) under bright light and dark room conditions.

284 uroshio Extension (KE) as it extends east of Japan ("upstream KE").

285 urgery departments across 21 institutions in Japan using the National Clinical Database (NCD) surgica

286 io 500 unit (Toshiba Medical Systems, Tokyo, Japan) using a multifrequency linear array 7.2-18.0-MHz

287 phy Aplio XG (Toshiba medical systems corp., Japan) using an 8-13 MHz linear transducer within 1 cm f

288 stratified according to geographical region (Japan vs rest of the world), number of organs with metas

289 Japan was the first country in the world to introduce cr

290 (the SP 100 Handy pachymeter (Tomey, Nagoya, Japan) was used for preoperative pachymetry and flap thi

291 t depth from an active system (Toki Granite, Japan), we show that, contrary to commonly proposed mode

292 recorded during 2000 Tottori earthquakes in Japan, we were able to detect and locate two times more

293 ected from ethnic Asian population living in Japan were compared with those of Caucasians living in t

294 BCG-Denmark and BCG-Japan were more immunogenic than BCG-Russia by the measu

295 camera (TRC-NW8, Topcon Corporation, Tokyo, Japan) were used to capture fundus images.

296 presenting three major ecosystems in Central Japan, where in situ time-lapse digital images documenti

297 sh/Irish (in the UK) and Japanese adults (in Japan) who were engaged in dyadic social interactions wi

298 rc FIT system (Kyowa Medex Co., Ltd., Tokyo, Japan) with a cut-off for positivity >=10 mug Hb/g faece

299 women aged 18 years or older (>/=20 years in Japan) with stage 1-3c (modified to stage 2-3c in Februa

300 ity and mortality in China, South Korea, and Japan, with key features of disease being intense fever,